{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:34:42Z","timestamp":1790674482060,"version":"4.1.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T00:00:00Z","timestamp":1491177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0174470","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T20:00:15Z","timestamp":1491249615000},"page":"e0174470","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson\u2019s disease"],"prefix":"10.1371","volume":"12","author":[{"given":"Irene","family":"Paterniti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Campolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Siracusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Cordaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Navarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6131-3690","authenticated-orcid":true,"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,4,3]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/ilar.48.4.339","article-title":"Nonhuman primate models of Parkinson's disease","volume":"48","author":"ME Emborg","year":"2007","journal-title":"ILAR journal \/ National Research Council, Institute of Laboratory Animal Resources"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00702-003-0102-y","article-title":"Diagnostic staging of Parkinson's disease: conceptual aspects","volume":"111","author":"H Przuntek","year":"2004","journal-title":"J Neural Transm"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"EC Hirsch","year":"2009","journal-title":"Lancet Neurol"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2009.06471.x","article-title":"Liver X receptor agonist treatment regulates inflammatory response after spinal cord trauma","volume":"112","author":"I Paterniti","year":"2010","journal-title":"Journal of neurochemistry"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s12035-013-8461-3","article-title":"LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases","volume":"48","author":"P Xu","year":"2013","journal-title":"Molecular neurobiology"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1172\/JCI9794","article-title":"Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice","volume":"107","author":"S Alberti","year":"2001","journal-title":"The Journal of clinical investigation"},{"issue":"21","key":"ref7","doi-asserted-by":"crossref","first-page":"13878","DOI":"10.1073\/pnas.172510899","article-title":"Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration","volume":"99","author":"L Wang","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1074\/jbc.M411420200","article-title":"The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease","volume":"280","author":"RP Koldamova","year":"2005","journal-title":"The Journal of biological chemistry"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.mcn.2007.01.011","article-title":"The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease","volume":"34","author":"DR Riddell","year":"2007","journal-title":"Molecular and cellular neurosciences"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2174\/1871527314666150821102823","article-title":"The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model","volume":"14","author":"R Siracusa","year":"2015","journal-title":"CNS & neurological disorders drug targets"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1742-2094-10-91","article-title":"A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury","volume":"10","author":"I Paterniti","year":"2013","journal-title":"Journal of neuroinflammation"},{"issue":"2\u20133","key":"ref12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0014-2999(79)90366-2","article-title":"Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity","volume":"57","author":"RD Porsolt","year":"1979","journal-title":"European journal of pharmacology"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"S Pellow","year":"1985","journal-title":"Journal of neuroscience methods"},{"issue":"13","key":"ref14","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1038\/npp.2009.118","article-title":"Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice","volume":"34","author":"M Bortolato","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"ref15","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-8993(01)02944-4","article-title":"Neuroprotective effect of riluzole in MPTP-treated mice","volume":"918","author":"T Araki","year":"2001","journal-title":"Brain research"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1021\/tx200082h","article-title":"Levodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: implications for the treatment of Parkinson's disease","volume":"24","author":"EA Liedhegner","year":"2011","journal-title":"Chemical research in toxicology"},{"issue":"2","key":"ref17","first-page":"341","article-title":"Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells","volume":"18","author":"X Song","year":"1997","journal-title":"Neurotoxicology"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-0102(00)00188-7","article-title":"Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT","volume":"38","author":"K Abe","year":"2000","journal-title":"Neuroscience research"},{"issue":"10","key":"ref19","first-page":"1360","article-title":"Ameliorating effects of curcumin on 6-OHDA-induced dopaminergic denervation, glial response, and SOD1 reduction in the striatum of hemiparkinsonian mice","volume":"17","author":"W Tripanichkul","year":"2013","journal-title":"European review for medical and pharmacological sciences"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00441-004-0954-y","article-title":"Neuronal pathology in Parkinson's disease","volume":"318","author":"JB Schulz","year":"2004","journal-title":"Cell and tissue research"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1073\/pnas.0500634102","article-title":"Inactivation of liver X receptor beta leads to adult-onset motor neuron degeneration in male mice","volume":"102","author":"S Andersson","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"PL McGeer","year":"1988","journal-title":"Neurology"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.21751","article-title":"Glial reactions in Parkinson's disease","volume":"23","author":"PL McGeer","year":"2008","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1007074420772","article-title":"Inflammatory mediators and modulation of blood-brain barrier permeability","volume":"20","author":"NJ Abbott","year":"2000","journal-title":"Cellular and molecular neurobiology"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"NJ Abbott","year":"2006","journal-title":"Nat Rev Neurosci"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999","article-title":"FcepsilonRII\/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells","volume":"19","author":"S Hunot","year":"1999","journal-title":"J Neurosci"},{"issue":"2","key":"ref27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0006-8993(92)91004-X","article-title":"Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death","volume":"587","author":"KM Boje","year":"1992","journal-title":"Brain research"},{"issue":"8","key":"ref28","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.4049\/jimmunol.149.8.2736","article-title":"Activated microglia mediate neuronal cell injury via a nitric oxide mechanism","volume":"149","author":"CC Chao","year":"1992","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"JR Vane","year":"1998","journal-title":"Annual review of pharmacology and toxicology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2003.tb07470.x","article-title":"Mitochondria, oxidative damage, and inflammation in Parkinson's disease","volume":"991","author":"MF Beal","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2174\/157015908785777201","article-title":"Cellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disorders","volume":"6","author":"GG Ortiz","year":"2008","journal-title":"Current neuropharmacology"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s12035-011-8225-x","article-title":"Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: is it all set to irrefutable clinical translation?","volume":"45","author":"NK Singhal","year":"2012","journal-title":"Molecular neurobiology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0174470","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:06:04Z","timestamp":1692749164000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0174470"}},"subtitle":[],"editor":[{"given":"Lucio","family":"Annunziato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,4,3]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0174470","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,3]]}}}